United Kingdom NET Patient Survey Quality of Life Results
#1062
Introduction: QoL is of paramount importance in patients diagnosed with cancer, this is especially true in patients with NETs since the median survival from diagnosis is 7 years.
Aim(s): This survey was conducted to assess the impact of NETs on the QoL of patients.
Materials and methods: INCA in conjunction with Novartis has performed the first global survey of patients with NETs. Hall & Partners fielded and analysed the results. The UK data reported in this abstract forms part of a much larger global survey which recruited >1900 patients. The UK data reported is based on 156 patients; average age = 57, 83% from England.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Bouvier C
Authors: Bouvier C, Sissons M, Srirajaskanthan R,
Keywords: Quality of life, NET,
To read the full abstract, please log into your ENETS Member account.